Revisiting anti-CTLA-4 antibodies in combination with PD-1 blockade for cancer immunotherapy
Mario Sznol, Ignacio Melero
Topics & Concepts
PembrolizumabMedicineLung cancerOncologyInternal medicineImmunotherapyNivolumabCancerAntibodyImmunologyCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesLung Cancer Research Studies